Masao Kaneki, Associate Professor at Massachusetts General Hospital, Harvard Medical School, obtained M.D. degree in 1987 and Ph.D. degree in 1995 from The University of Tokyo. He is a molecular biologist and a trained physician-scientist and has a broad background in molecular biology and biochemistry, with specific expertise on metabolism, intracellular signal transduction, insulin resistance and critical illness (e.g., sepsis, burn). Major efforts of his research team have been focused on the molecular pathogenesis of inflammatory human diseases, including burn injury, sepsis and obesity-induced diabetes, from the standpoint of signal transduction and metabolism. Overall, his research team has employed an integrated basic, translational and reverse translational approach, including studies using cell culture system, mechanistic studies in genetically engineered mice, pharmacological studies in rodent models of human diseases, and clinical studies. Membership: Shock Society, American Burn Association, American Society for Anesthesiologists and American Diabetes Association.